161 related articles for article (PubMed ID: 8673542)
1. Inhibition of HIV replication by sense and antisense rev response elements in HIV-based retroviral vectors.
Kim JH; McLinden RJ; Mosca JD; Vahey MT; Greene WC; Redfield RR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):343-51. PubMed ID: 8673542
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 multiplication in a human CD4+ lymphocytic cell line expressing antisense and sense RNA molecules containing HIV-1 packaging signal and Rev response element(s).
Cohli H; Fan B; Joshi RL; Ramezani A; Li X; Joshi S
Antisense Res Dev; 1994; 4(1):19-26. PubMed ID: 7914762
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW; Gallardo HF; Gilboa E; Smith C
J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
[TBL] [Abstract][Full Text] [Related]
4. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time.
Sherpa C; Jackson PEH; Gray LR; Anastos K; Le Grice SFJ; Hammarskjold ML; Rekosh D
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867301
[TBL] [Abstract][Full Text] [Related]
6. A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression.
Mann DA; Mikaélian I; Zemmel RW; Green SM; Lowe AD; Kimura T; Singh M; Butler PJ; Gait MJ; Karn J
J Mol Biol; 1994 Aug; 241(2):193-207. PubMed ID: 8057359
[TBL] [Abstract][Full Text] [Related]
7. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
[TBL] [Abstract][Full Text] [Related]
8. The HIV-1 Rev protein enhances encapsidation of unspliced and spliced, RRE-containing lentiviral vector RNA.
Grewe B; Ehrhardt K; Hoffmann B; Blissenbach M; Brandt S; Uberla K
PLoS One; 2012; 7(11):e48688. PubMed ID: 23133650
[TBL] [Abstract][Full Text] [Related]
9. Role of Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) in the propagation of MPMV vectors by genetic complementation using homologous/heterologous env genes.
Rizvi TA; Lew KA; Murphy EC; Schmidt RD
Virology; 1996 Oct; 224(2):517-32. PubMed ID: 8874512
[TBL] [Abstract][Full Text] [Related]
10. A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals.
Brighty DW; Rosenberg M
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8314-8. PubMed ID: 8078879
[TBL] [Abstract][Full Text] [Related]
11. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
Mautino MR; Morgan RA
Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
[TBL] [Abstract][Full Text] [Related]
14. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.
Kotsopoulou E; Kim VN; Kingsman AJ; Kingsman SM; Mitrophanous KA
J Virol; 2000 May; 74(10):4839-52. PubMed ID: 10775623
[TBL] [Abstract][Full Text] [Related]
15. Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture.
Bahner I; Kearns K; Hao QL; Smogorzewska EM; Kohn DB
J Virol; 1996 Jul; 70(7):4352-60. PubMed ID: 8676458
[TBL] [Abstract][Full Text] [Related]
16. Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene.
Ward AM; Rekosh D; Hammarskjold ML
J Virol; 2009 Jan; 83(2):940-52. PubMed ID: 18971264
[TBL] [Abstract][Full Text] [Related]
17. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
Fang J; Kubota S; Yang B; Zhou N; Zhang H; Godbout R; Pomerantz RJ
Virology; 2004 Dec; 330(2):471-80. PubMed ID: 15567440
[TBL] [Abstract][Full Text] [Related]
18. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing.
Schwartz S; Felber BK; Pavlakis GN
Virology; 1991 Aug; 183(2):677-86. PubMed ID: 1830183
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
20. Expression of chimeric neo-Rev response element sequences interferes with Rev-dependent HIV-1 Gag expression.
Zimmermann K; Weber S; Dobrovnik M; Hauber J; Böhnlein E
Hum Gene Ther; 1992 Apr; 3(2):155-61. PubMed ID: 1391035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
